Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of targeted biopsy, perilesional biopsy, and random biopsy in prostate cancer diagnosis by mpMRI/transrectal ultrasonography fusion biopsy.
Novara G, Zattoni F, Zecchini G, Aceti A, Pellizzari A, Ferraioli G, Carlesso M, La Bombarda G, Morlacco A, Lacognata CS, Lauro A, Gardiman M, Betto G, Zanovello N, Moro FD. Novara G, et al. Among authors: lauro a. World J Urol. 2023 Nov;41(11):3239-3247. doi: 10.1007/s00345-023-04382-3. Epub 2023 Apr 20. World J Urol. 2023. PMID: 37079076
Does 1.5 T mpMRI play a definite role in detection of clinically significant prostate cancer? Findings from a prospective study comparing blind 24-core saturation and targeted biopsies with a novel data remodeling model.
Dal Moro F, Zecchini G, Morlacco A, Gardiman MP, Lacognata CS, Lauro A, Rugge M, Prayer Galetti T, Zattoni F. Dal Moro F, et al. Among authors: lauro a. Aging Clin Exp Res. 2019 Jan;31(1):115-123. doi: 10.1007/s40520-018-0939-4. Epub 2018 Apr 3. Aging Clin Exp Res. 2019. PMID: 29616473
Role of targeted biopsy, perilesional biopsy, random biopsy, and their combination in the detection of clinically significant prostate cancer by mpMRI/transrectal ultrasonography fusion biopsy in confirmatory biopsy during active surveillance program.
Novara G, Zattoni F, Zecchini G, Aceti A, Pellizzari A, Ferraioli G, Cobacchini C, Taverna A, Sattin F, Carletti F, La Bombarda G, Lacognata CS, Lauro A, Gardiman M, Morlacco A, Betto G, Dal Moro F. Novara G, et al. Among authors: lauro a. Prostate Cancer Prostatic Dis. 2024 Mar;27(1):129-135. doi: 10.1038/s41391-023-00733-8. Epub 2023 Oct 12. Prostate Cancer Prostatic Dis. 2024. PMID: 37828151
Real Results from Virtual Sedation: Application to Colonoscopy.
Tomasello G, Burgio S, Pitruzzella A, Carini F, Chiodo R, Bartolomeo D, Canzio D, Ancona A, Lauro A, D'Andrea V. Tomasello G, et al. Among authors: lauro a. Dig Dis Sci. 2025 Jan 18. doi: 10.1007/s10620-024-08689-y. Online ahead of print. Dig Dis Sci. 2025. PMID: 39826060 No abstract available.
Development of a recombinant human IgG1 monoclonal antibody against the TRBV5-1 segment of the T cell receptor for the treatment of mature T cell neoplasms.
Pitaro M, Antonini G, Arcovito A, Buccisano F, De Lauro A, Irno Consalvo M, Gallo V, Giacon N, Mangiatordi GF, Pacelli M, Pitaro MT, Polticelli F, Sorrenti M, Venditti A. Pitaro M, et al. Among authors: de lauro a. Front Immunol. 2024 Dec 17;15:1520103. doi: 10.3389/fimmu.2024.1520103. eCollection 2024. Front Immunol. 2024. PMID: 39742266 Free PMC article.
337 results